Literature DB >> 11939878

Chlorpromazine and the psychopharmacologic revolution.

Michael Rosenbloom1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11939878

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 2.  Biomedical Explanations of Psychopathology and Their Implications for Attitudes and Beliefs About Mental Disorders.

Authors:  Matthew S Lebowitz; Paul S Appelbaum
Journal:  Annu Rev Clin Psychol       Date:  2018-11-16       Impact factor: 18.561

3.  New information of dopaminergic agents based on quantum chemistry calculations.

Authors:  Guillermo Goode-Romero; Ulrika Winnberg; Laura Domínguez; Ilich A Ibarra; Rubicelia Vargas; Elisabeth Winnberg; Ana Martínez
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

4.  Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment.

Authors:  Pareesa Kamgar-Dayhoff; Tinatin I Brelidze
Journal:  Oncotarget       Date:  2021-07-06

5.  A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease.

Authors:  Ana Martínez; Ilich A Ibarra; Rubicelia Vargas
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

6.  The Quest for Psychiatric Advancement through Theory, beyond Serendipity.

Authors:  Robert E Kelly; Anthony O Ahmed; Matthew J Hoptman; Anika F Alix; George S Alexopoulos
Journal:  Brain Sci       Date:  2021-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.